Rome, Nov 9. (Adnkronos Health) – “Unfortunately, we continue to chase scientific innovation. We hope that the reform of the pharmaceutical system can make our country more competitive, because we are competing with giants like the United States and China. It is time for Europe to believe more in innovation, and for our country to believe more in it too. We have been pioneers, because this reform aims to unlock bureaucracy and bring medicine closer and closer to the citizen.” This was stated by Loreto Gesualdo, president of Fism – Federation of Italian Medical-Scientific Societies, at the event ‘The future of pharmaceutical legislation: a systemic vision’, organized by Nuove Reti today in Rome.
“But unlocking bureaucracy is not enough – Gesualdo warns – we must invest in clinical research. We need to make the Italian healthcare system more competitive. In particular, we need to invest in clinical research to increase the number of trials proposed to us globally, which many times we are unable to meet due to time constraints. We need to become much faster: we have an Italian system ready to welcome innovation and we have excellent doctors, but sometimes we lack organizational models,” he added.
Gesualdo therefore hopes “that new forms of organization can be found in the implementing decrees. We are focusing heavily on study coordinators, data managers, and research nurses. I am sure that these proposals of ours will be taken up by the government, will find practical application, and will make our system increasingly competitive,” he concluded.